Porphyromonas Gingivalis Fimbriae
Overview
Authors
Affiliations
Marginal periodontitis is not a homogeneous disease but is rather influenced by an intricate set of host susceptibility differences as well as diversities in virulence among the harbored organisms. It is likely that clonal heterogeneity of subpopulations with both high and low levels of pathogenicity exists among organisms harbored by individuals with negligible, slight, or even severe periodontal destruction. Therefore, specific virulent clones of periodontal pathogens may cause advanced and/or aggressive periodontitis. Porphyromonas gingivalis is a predominant periodontal pathogen that expresses a number of potential virulence factors involved in the pathogenesis of periodontitis, and accumulated evidence shows that its expression of heterogenic virulence properties is dependent on clonal diversity. Fimbriae are considered to be critical factors that mediate bacterial interactions with and invasion of host tissues, with P. gingivalis shown to express two distinct fimbria-molecules, long and short fimbriae, on the cell surface, both of which seem to be involved in development of periodontitis. Long fimbriae are classified into six types (I to V and Ib) based on the diversity of fimA genes encoding FimA (a subunit of long fimbriae). Studies of clones with type II fimA have revealed their significantly greater adhesive and invasive capabilities as compared to other fimA type clones. Long and short fimbriae induce various cytokine expressions such as IL-1α, IL-β, IL-6, and TNF-α, which result in alveolar bone resorption. Although the clonal diversity of short fimbriae is unclear, distinct short fimbria-molecules have been found in different strains. These fimbriae variations likely influence the development of periodontal disease.
Natarajan P J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4731-S4740.
PMID: 40061649 PMC: 11888705. DOI: 10.4103/jpbs.jpbs_1235_24.
Ferreira da Silva A, Gomes A, Goncalves L, Fernandes A, Almeida A Pharmaceutics. 2025; 17(2).
PMID: 40006510 PMC: 11858903. DOI: 10.3390/pharmaceutics17020141.
Virkkunen S, Kaarela T, Laine M, Suominen A, Hagstrom J, Sorsa T Clin Exp Dent Res. 2025; 11(1):e70098.
PMID: 39967031 PMC: 11835764. DOI: 10.1002/cre2.70098.
and canine periodontal disease: Current understanding and future directions.
Kwack K, Jang E, Kim C, Choi Y, Lee J, Moon J Virulence. 2025; 16(1):2449019.
PMID: 39834343 PMC: 11756583. DOI: 10.1080/21505594.2024.2449019.
Hu P, Xie S, Shi B, Tansky C, Circello B, Sagel P Microorganisms. 2025; 12(12.
PMID: 39770870 PMC: 11728304. DOI: 10.3390/microorganisms12122668.